114 related articles for article (PubMed ID: 37322978)
1. Predicting the prognosis of HER2-positive breast cancer patients by fusing pathological whole slide images and clinical features using multiple instance learning.
Wang Y; Zhang L; Li Y; Wu F; Cao S; Ye F
Math Biosci Eng; 2023 Apr; 20(6):11196-11211. PubMed ID: 37322978
[TBL] [Abstract][Full Text] [Related]
2. Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning.
Yang J; Ju J; Guo L; Ji B; Shi S; Yang Z; Gao S; Yuan X; Tian G; Liang Y; Yuan P
Comput Struct Biotechnol J; 2022; 20():333-342. PubMed ID: 35035786
[TBL] [Abstract][Full Text] [Related]
3. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
Fremond S; Andani S; Barkey Wolf J; Dijkstra J; Melsbach S; Jobsen JJ; Brinkhuis M; Roothaan S; Jurgenliemk-Schulz I; Lutgens LCHW; Nout RA; van der Steen-Banasik EM; de Boer SM; Powell ME; Singh N; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Smit VTHBM; Creutzberg CL; Horeweg N; Koelzer VH; Bosse T
Lancet Digit Health; 2023 Feb; 5(2):e71-e82. PubMed ID: 36496303
[TBL] [Abstract][Full Text] [Related]
4. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
[TBL] [Abstract][Full Text] [Related]
5. Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR
Hu J; Lv H; Zhao S; Lin CJ; Su GH; Shao ZM
J Thorac Dis; 2023 May; 15(5):2528-2543. PubMed ID: 37324098
[TBL] [Abstract][Full Text] [Related]
6. Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study.
Kather JN; Krisam J; Charoentong P; Luedde T; Herpel E; Weis CA; Gaiser T; Marx A; Valous NA; Ferber D; Jansen L; Reyes-Aldasoro CC; Zörnig I; Jäger D; Brenner H; Chang-Claude J; Hoffmeister M; Halama N
PLoS Med; 2019 Jan; 16(1):e1002730. PubMed ID: 30677016
[TBL] [Abstract][Full Text] [Related]
7. ICSDA: a multi-modal deep learning model to predict breast cancer recurrence and metastasis risk by integrating pathological, clinical and gene expression data.
Yao Y; Lv Y; Tong L; Liang Y; Xi S; Ji B; Zhang G; Li L; Tian G; Tang M; Hu X; Li S; Yang J
Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36242564
[TBL] [Abstract][Full Text] [Related]
8. Prototypical multiple instance learning for predicting lymph node metastasis of breast cancer from whole-slide pathological images.
Yu JG; Wu Z; Ming Y; Deng S; Li Y; Ou C; He C; Wang B; Zhang P; Wang Y
Med Image Anal; 2023 Apr; 85():102748. PubMed ID: 36731274
[TBL] [Abstract][Full Text] [Related]
9. TGMIL: A hybrid multi-instance learning model based on the Transformer and the Graph Attention Network for whole-slide images classification of renal cell carcinoma.
Sun X; Li W; Fu B; Peng Y; He J; Wang L; Yang T; Meng X; Li J; Wang J; Huang P; Wang R
Comput Methods Programs Biomed; 2023 Dec; 242():107789. PubMed ID: 37722310
[TBL] [Abstract][Full Text] [Related]
10. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided prognosis on breast cancer with hematoxylin and eosin histopathology images: A review.
Chen JM; Li Y; Xu J; Gong L; Wang LW; Liu WL; Liu J
Tumour Biol; 2017 Mar; 39(3):1010428317694550. PubMed ID: 28347240
[TBL] [Abstract][Full Text] [Related]
12. Accurate diagnosis and prognosis prediction of gastric cancer using deep learning on digital pathological images: A retrospective multicentre study.
Huang B; Tian S; Zhan N; Ma J; Huang Z; Zhang C; Zhang H; Ming F; Liao F; Ji M; Zhang J; Liu Y; He P; Deng B; Hu J; Dong W
EBioMedicine; 2021 Nov; 73():103631. PubMed ID: 34678610
[TBL] [Abstract][Full Text] [Related]
13. Use of Deep Learning to Develop and Analyze Computational Hematoxylin and Eosin Staining of Prostate Core Biopsy Images for Tumor Diagnosis.
Rana A; Lowe A; Lithgow M; Horback K; Janovitz T; Da Silva A; Tsai H; Shanmugam V; Bayat A; Shah P
JAMA Netw Open; 2020 May; 3(5):e205111. PubMed ID: 32432709
[TBL] [Abstract][Full Text] [Related]
14. Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study.
Liu Y; Wang Y; Wang Y; Xie Y; Cui Y; Feng S; Yao M; Qiu B; Shen W; Chen D; Du G; Chen X; Liu Z; Li Z; Yang X; Liang C; Wu L
EClinicalMedicine; 2022 Oct; 52():101562. PubMed ID: 35928032
[TBL] [Abstract][Full Text] [Related]
15. Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer.
Farahmand S; Fernandez AI; Ahmed FS; Rimm DL; Chuang JH; Reisenbichler E; Zarringhalam K
Mod Pathol; 2022 Jan; 35(1):44-51. PubMed ID: 34493825
[TBL] [Abstract][Full Text] [Related]
16. Analytical Validation of the PreciseDx Digital Prognostic Breast Cancer Test in Early-Stage Breast Cancer.
Fernandez G; Zeineh J; Prastawa M; Scott R; Madduri AS; Shtabsky A; Jaffer S; Feliz A; Veremis B; Mejias JC; Charytonowicz E; Gladoun N; Koll G; Cruz K; Malinowski D; Donovan MJ
Clin Breast Cancer; 2024 Feb; 24(2):93-102.e6. PubMed ID: 38114366
[TBL] [Abstract][Full Text] [Related]
17. Data-Efficient Computational Pathology Platform for Faster and Cheaper Breast Cancer Subtype Identifications: Development of a Deep Learning Model.
Bae K; Jeon YS; Hwangbo Y; Yoo CW; Han N; Feng M
JMIR Cancer; 2023 Sep; 9():e45547. PubMed ID: 37669090
[TBL] [Abstract][Full Text] [Related]
18. Biased data, biased AI: deep networks predict the acquisition site of TCGA images.
Dehkharghanian T; Bidgoli AA; Riasatian A; Mazaheri P; Campbell CJV; Pantanowitz L; Tizhoosh HR; Rahnamayan S
Diagn Pathol; 2023 May; 18(1):67. PubMed ID: 37198691
[TBL] [Abstract][Full Text] [Related]
19. Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma.
Feng M; Deng Y; Yang L; Jing Q; Zhang Z; Xu L; Wei X; Zhou Y; Wu D; Xiang F; Wang Y; Bao J; Bu H
Diagn Pathol; 2020 May; 15(1):65. PubMed ID: 32471471
[TBL] [Abstract][Full Text] [Related]
20. Computer-extracted features of nuclear morphology in hematoxylin and eosin images distinguish stage II and IV colon tumors.
Kumar N; Verma R; Chen C; Lu C; Fu P; Willis J; Madabhushi A
J Pathol; 2022 May; 257(1):17-28. PubMed ID: 35007352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
